At the 4th edition of the Longevity Med Summit in London, Prof. Wolf Reik, MD, Director of the Altos Cambridge Institute of Science, will deliver a keynote presentation on Cellular Reprogramming and Disease Reversal. In his session, Prof. Reik will introduce Altos Labs’ mission to reverse disease by restoring cell health and resilience through cellular rejuvenation. He will highlight groundbreaking discoveries showing that transient reprogramming with Yamanaka factors can rejuvenate cells, tissues, and even entire organisms, offering a powerful foundation for next-generation longevity interventions. Building on this progress, Prof. Reik will share how current research at Altos focuses on uncovering safe, precise, and controllable pathways for epigenetic rejuvenation. This work aims to pave the way for a new class of therapeutics capable of resetting cellular function, reversing disease processes at their root, and ultimately extending human healthspan through targeted cellular restoration.